Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
26.62
+0.74 (2.86%)
Oct 30, 2026, 3:04 PM CST

Huadong Medicine Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
43,96743,61241,90640,62437,71534,563
Revenue Growth
2.03%4.07%3.16%7.71%9.12%2.61%
Gross Profit
13,94714,10313,89913,15612,02810,595
Operating Income
3,9894,1224,3413,5903,1552,806
Net Income
3,4383,4143,5122,8392,4992,302
Earnings Per Share
1.961.952.001.621.431.32
EPS Growth
-6.91%-2.84%23.61%13.47%8.58%-18.37%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Medical Beauty Business
1,399
Manufacturing
14,556
Intersegment Elimination
-3,235
Commercial Business
30,488
Total
43,208

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
4,1155,0545,2764,6633,9964,032
Total Debt
2,0742,1223,0311,9382,5862,089
Net Cash (Debt)
2,0402,9312,2462,7261,4111,944
Net Cash Growth
-2.70%30.53%-17.61%93.21%-27.43%62.16%
Net Cash Per Share
1.161.671.281.560.811.11

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
3,4964,2463,7493,9292,3823,170
Capital Expenditures
-1,238-1,574-1,728-1,607-1,193-819.1
Free Cash Flow
2,2572,6712,0212,3231,1892,351
Free Cash Flow Growth
14.54%32.17%-12.98%95.40%-49.44%21.26%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
31.72%32.34%33.17%32.38%31.89%30.65%
Operating Margin
9.07%9.45%10.36%8.84%8.37%8.12%
Pretax Margin
9.13%9.21%10.26%8.53%8.04%8.18%
Profit Margin
7.82%7.83%8.38%6.99%6.63%6.66%
FCF Margin
5.13%6.13%4.82%5.72%3.15%6.80%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.9300.9300.9300.5800.2900.290
Dividend Per Share Growth
0%0%60.35%100.00%0%26.09%
Dividend Yield
3.49%2.36%2.70%1.40%0.62%0.72%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
13.5820.2217.2425.5632.8530.56
Forward PE
14.2418.9819.8327.5730.3929.34
P/FCF Ratio
20.6825.8429.9631.2469.0629.92
PS Ratio
1.061.581.451.792.182.04